Peter Thiel is an American billionaire entrepreneur, venture capitalist, and co-founder of PayPal. Peter Thiel's investments in Immunochina and Abcellera underscore his dedication to advancing transformative breakthroughs in the field of oncology. These companies are at the forefront of oncology research, employing innovative approaches to harness the power of the immune system in the fight against cancer. Thiel's strategic backing of Immunochina and Abcellera highlights his commitment to accelerating progress in oncology treatments and therapies, with the ultimate goal of improving outcomes for cancer patients worldwide.